Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 229,504 | 311,770 | 380,724 | 455,897 | 342,735 |
| Cost of Goods | 9,505 | 18,476 | 72,598 | 87,414 | 67,898 |
| Gross Profit | 219,999 | 293,294 | 308,126 | 368,483 | 274,837 |
| Operating Expenses | 414,932 | 250,111 | 350,904 | 344,388 | 326,135 |
| Operating Income | -194,428 | 43,659 | -42,180 | 24,509 | -50,400 |
| Interest Expense | 58,389 | 68,881 | 73,552 | 83,719 | 73,436 |
| Other Income | 30,333 | 63,197 | 11,807 | -5,292 | 599 |
| Pre-tax Income | -222,484 | 37,975 | -103,925 | -64,502 | -123,237 |
| Income Tax | -5,283 | 1,067 | -1,429 | 24,218 | -47,499 |
| Net Income Continuous | -217,201 | 36,908 | -102,496 | -88,720 | -75,738 |
| Net Income | $-217,201 | $36,908 | $-102,496 | $-88,720 | $-75,738 |
| EPS Basic Total Ops | -12.28 | 2.32 | -6.52 | -5.80 | -5.04 |
| EPS Basic Continuous Ops | -12.29 | 2.31 | -6.54 | -5.79 | -5.04 |
| EPS Diluted Total Ops | -12.28 | 2.28 | -6.52 | -5.80 | -5.04 |
| EPS Diluted Continuous Ops | -12.29 | 2.30 | -6.54 | -5.79 | -5.04 |
| EPS Diluted Before Non-Recurring Items | -12.28 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-67,718 | $171,962 | $82,737 | $151,557 | $50,966 |